Dysmorphology
Contemporary dysmorphology preserves many features of earlier forms of physiognomy and iconography; however, in recent years, it has also been subject to increasing technical change. It thus stands at the crossroads of the old clinic and the new technologies of genomic science. Dysmorphology represents a traditional clinical area that is increasingly using genetic technologies in ways that redefine clinical work. Diagnosis and clinical classification are being reshaped by genetic technologies. Thus, clinical dysmorphology parallels other clinical areas such as neurology, oncology and infertility and represents an important site where clinical medicine and genetic science intersect.
Dysmorphology refers to the professional discipline of delineating disorders affecting the physical development of the individual, before or after birth, and includes the recognition of specific patterns of physical features in patients with a range of problems (Aase 1990 ). These features may be associated with abnormalities but need not be abnormal in themselves. However, particular patterns of physical features have come to be associated with underlying systems abnormalities such as heart defects, or delayed intellectual development. Patients are mainly babies, children and teenagers or young adults. When patterns of malformations are deemed to have reached a level of regularity across different cases and are thought to arise from a single underlying pathogenetic mechanism, they are named as a syndrome.
There are several thousand named syndromes currently held within international clinical databases and textbooks. The majority of syndromes are associated with a genetic basis.
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The specific features that characterise clinical dysmorphology include: the recognition and classification of specific patterns of facial and other physical features; ongoing classification based on clinical diagnosis and examination; increasing use and interpretation of molecular tests in diagnosis and clinical classification; decisionmaking and assessment distributed and networked between different experts (including scientists and clinicians) at local, regional and national levels; and variable outcomes, for example, the introduction of new clinical categories and diagnostic labels. Thus, the examination of the field of dysmorphology reveals a speciality that displays the interaction of genetic technologies and clinical judgement. Shaw's analysis of the exercise of judgment by dysmorphology specialists provides a parallel example to our own (Shaw 2003) .
In the course of this paper, we shall locate the visual culture of dysmorphology within the wider history of medical representation. We shall consider this in terms of the 'spectacular display' of the clinic. We shall discuss the dysmorphology experts competence is 'seeing' cases and interpreting visual representations. This is in turn repeated in the expert's right to make 'oracular pronouncements' concerning the patient's characteristic appearance and its clinical significance. We go on to discuss the intersection of genetic technologies and clinical judgement in the identification of dysmorphic conditions. We conclude by affirming the continued significance of 'the clinic' and the importance of resisting premature or over-simplified appeals to geneticization or technologically driven reductionism.
The spectacle of the clinic
For centuries, the clinic has been a site for the spectacular display and representation of bodies, organs and pathologies. The clinical spectacle has taken many forms and these include the public dissection and the anatomy lesson; the clinical lecture; the ward round; the teaching round; the grand round and the clinico-pathological conference. Michel Foucault (1982) Consequently, we need to preserve Foucault's concern with the technologies of inspection and medical inference, while continuing to investigate the modalities of medical perception (cf. Casper and Berg 1995; Berg and Mol 1997) . We concentrate on the spectacular presentation and representation of patients, their bodies and their identities within the clinical space defined by contemporary genetic medicine. We suggest that a broad historical and cultural pattern can be traced that brings together the spectacular display and the oracular pronouncement as long-standing (although by no means immutable) features of medical knowledge and the importance of a deeply entrenched visual and oral culture in the creation and transmission of medical knowledge. We trace the intersection of visual culture and nosographic classification in the genetic clinic.
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The social forms of the spectacle are various, and have their own longue durée. The early modern anatomy lesson (Sawday 1995; Richardson 1988 The practice of physiognomy has a long history. The identification of character and temperament through physical appearance has been deeply rooted in the iconography of Western art and science. Leroi (2003) provides a recent guide to the long history of representations of abnormal appearances and the particular fascination they have held for medical science and the popular imagination. Appearance has long been thought to reveal the inner character of the person; as Kemp and Wallace (2000: 94) suggest; '... philosophy, science and medicine have been consistently mobilized over the ages to provide a framework of explanation of how inner is expressed in outer'. Photography paralleled and expanded upon the representational practices of the fine arts by depicting types, characters and pathologies. The image of the racially inferior specimen, the sexual stereotype or the delusional inmate became fixed on the photographic plate.
The modern clinic is now suffused with images of patients as well as images and representations of their tissues, organs and lesions. The range of technologies has been expanded and the visual penetration of the 'inner' and the 'microscopic' has been extended. The body is variously sectioned, imaged, stained, visually enhanced by false colour, and rendered visible through a diverse range of technologies. However, the photographic image of the individual patient, and the inspection of her or his appearance persists. Such presentations are also sites for the enactment of oracular authority by genetic scientists and clinicians (cf. Atkinson 1995 Atkinson , 2004 .
Within this paper, we show how visual display and the rhetoric of clinical authority are long standing features of dysmorphology to demonstrate that even when new molecular technologies are used, clinical judgement is still central. The material drawn on in this paper is taken from a wider ethnography of clinical genetic work and is based on fieldwork carried out within a clinical genetics service based in a wellestablished UK regional genetics service.
Methods
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Within this ethnographic study, one clinical genetics team and their patient population were followed over a period of 9 months, from November 2002 to July 2003. Clinic consultations (n=37) were observed within clinics (n=12) based in three local hospitals. Although the caseload of the clinical team was not dedicated to dysmorphology cases, a large number of their referrals (32) involved dysmorphology.
The average length of time allocated to each consultation was one hour and this generated 44 hours of observation, yielding notes that included near-verbatim text.
We also observed local professional dysmorphology meetings (n= 6) where cases were presented and discussed. In addition, a large number of less formal encounters between professionals was observed.
Selection criteria included referral for dysmorphic features, willingness to participate, and the clinical team's assessment that participation was appropriate.
Because of the nature of the conditions under observation, the majority of patients were children, which necessitated full involvement and consideration of parents and other family members in the study. Where feasible, informed consent was obtained from all family members present in the clinic, with the exception of a number of occasions where very young children were involved or where the child's learning disabilities meant that it would have been unrealistic or unduly invasive to seek consent. In such cases, proxy consent was obtained from parents. This project was approved by the Multi-centre Research Ethics Committee. All names have been changed to preserve anonymity.
Spectacular display
As we have emphasised, visual display is a long-standing feature of medical Where photographic evidence is available (either accidentally within group family photographs or because they are specifically requested by the team), the physical features of other family members are examined, discussed and compared. This is part of the process of establishing whether a feature is within the normal range, the team 'read' the photographs for visual signs of dysmorphism.
The clinical consultation concerns a five year old boy who has been referred with 'a large head and learning difficulties'. After taking a history, the consultant examines him; looking closely at his ears, his forehead, his eyes, using a small light to look in his mouth to examine his teeth and tongue. She examines his limbs, compares his fingers, and toes and after noting his 'loose of 'seeing' such features and being able to distinguish when a feature deviates from the normal range. However, such features are also compared with the child's immediate family -it may be outside the normal range, but a benign feature within this particular kindred. In the case above, the child's hair distribution is evaluated and the unusual hairiness on his back are commented on, as is the general density of his hair. It is important to establish whether such a feature is familial because if not, it may be a clue to an underlying syndrome. For example, very sparse hair is associated with a number of syndromes that involve teeth and other ectodermal structures.
However, the clinician is cautious; the child may just have hair like his father and sister. This does not mean that she brings to an end the search for an underlying syndrome, rather she moves on to another potential classification, the 'straight eyebrows' may be significant. We all move our chairs to face one wall where a fuzzy out-of-focus picture of a face is projected. A junior is at the controls, however; she cannot get the picture to focus and the two consultants help. Finally, it comes into focus and shows a head and shoulders of an attractive little boy, smiling into the camera. In the extract above, the consultant has identified a number of subtle signs, however, although these features generally suggest an underlying genetic change, they do not point to a specific syndrome. In such cases, the consultant routinely confers with colleagues locally. An important feature of these slides is that other professionals can see them; patients are presented in absentia and classification can be based on visual and laboratory evidence alone. They are a form of representation of the patient that can travel to other specialists and can be presented to colleagues locally, nationally and internationally if a case proves particularly subtle, interesting or difficult to classify.
Visual representation is fundamental to the creation and transmission of medical knowledge (Cartwright 1995; Kevles 1997 It is important not only to 'see' a syndrome but also to have collected a case, that is, to make a diagnosis and to have a photographic record. The images become part of the dysmorphologist's personal collection and if the syndrome is particularly 'rare' or interesting, the case can be presented at national or international meetings.
As soon as we gather for the local dysmorphology meeting, one of the consultants cannot contain herself she is so excited, she exclaims 'I'm This case is particularly interesting to the clinical team for a number of reasons. To have identified a rare or unusual syndrome such as this has the distinction of increasing expertise generally, but actually 'seeing' this syndrome also confers a specific authority over the syndrome. In this case, the mother is a 'classic', she had 'the full house'; that is, she displays all the main features and abnormalities associated with the condition. However, because the daughter is similarly affected this case has the added distinction of also being 'rare' because the known aetiology of the syndrome is that it occurs sporadically and is not familial.
Seeing a number of such rare cases and securing that expertise through presentations and publications can lead to the local, national or international recognition of a clinician's skill to adjudicate upon difficult diagnostic decisions such as cases on the boundaries of a syndrome. Syndromes are also named by or after a clinician (for example Down's syndrome) and the clinicians themselves can be named after a syndrome. The team occasionally discussed whether to send borderline cases to such experts as the final arbiter of a diagnosis. For example, the 'White Matter Queen' (an expert at interpreting brain anomalies), the 'Rett Queen' (an expert on Rett syndrome, a common cause of profound intellectual disability in girls. It usually presents with stagnation of development in infancy and then a progressive loss of skills leading to profound mental and physical disability) and the 'Angelman Queen' (an expert on Angelman syndrome, a condition which causes severe developmental delay, and is characterised by an abnormal gait, characteristic facial features and often inappropriate laughter). Similarly, colleagues may have a local reputation for 'seeing' particular syndromes. For example, during a case review the consultant suggests that they send photographs of the child to a colleague who 'is good at spotting Marfan's'
(the physical features of Marfan syndrome include a tendency towards tall stature, joint laxity, high palate and dental crowding, and long fingers and toes). The opinion of such colleagues is treated with a greater degree of trust, they were often asked to adjudicate on borderline or disputed cases and such classifications are then less likely to be called into question.
The photograph is also a portable form of representation of the individual, which can be presented, mailed or emailed to other experts, locally, nationally or internationally. Discussion and adjudication of cases can be based on this technology alone. Even if the consultant cannot 'see' a syndrome, one feature may be enough to indicate that the problems have a genetic base and should be investigated further. The process of knowledge-transmission from consultant to trainee includes ensuring that the junior colleagues 'see a syndrome': to see one in the clinic is also to be able to classify one. Over 3,000 conditions and syndromes have been described To obtain the skill of assessing and classifying cases, the craft skill of seeing is emphasised.
After lunch the consultant, the Genetic Nurse Specialist and the trainee discuss the cases to be seen that afternoon. The consultant looks in the medical records of the next case, a ten-year-old boy referred for short stature and states 'it's a Russell-Silver', the trainee responds 'we've been looking for Interestingly, the photograph can also be dismissed in favour of the 'eye' of the expert. Despite the importance of the photographs and slides, the examination of the patient in the clinic is often emphasised. Photographs can be out of date and their reliability can be questioned. The lens of the camera can lie; it can enhance, eliminate or distort a 'look' or a feature.
In the team meeting after the clinic, they discuss the case of Sophie, a fiveyear-old girl who is blind and has severe learning disabilities. Her mother is very young and anxious that she has caused her daughter's problems. The consultant has looked up the child's problems and malformations on a dysmorphology database and although she suggests a number of potential syndromes, they have difficulty finding a classification that would 'fit'. The MRI scan failed to reveal anything, but the team agrees that the photographs indicate that she looks 'a bit dysmorphic'. However, the genetic nurse specialist has seen the girl during her home visit and although she agrees that some dysmorphic features are present, she disputes that the child has the 'look' of any of the potential syndromes the team think they can see in the photographs. The consultant agrees that you 'really have to see the children'.
[Clinic 9, patient 4]
Here a locally well-respected and experienced genetic nurse specialist has the status to pronounce on whether a 'look' that fits a particular syndrome is present. There is an important distinction between being able to identify one or a number of potentially dysmorphic features and the expertise of being able to recognise 'the look' of a syndrome. Implicit within this exchange is trust; the trustworthiness of a diagnosis is often dependent upon who is making the observation.
Oracular pronouncement
The spectacular display of the body or its image is paralleled by the oracular pronouncement of the senior clinician. In this section, we show how clinical authority is displayed through the narration of professional 'experience' and the ability to see and de-code the signs of diseases.
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Medicine has been transmitted from teacher to student through encounters that endure, in form, from generation to generation themselves. The clinical 'round' has provided an encounter in which senior practitioners can demonstrate and expatiate on hospital patients since the earliest years of clinical instruction. The round has provided the opportunity for the junior hospital doctor to present a series of patients to the consulting physician or surgeon since the seventeenth century (this is one respect in which Foucault's periodisation of the modern clinic is not universal). The teaching hospital provides a variety of more or less formal occasions in which patients are 'presented' and discussed (Atkinson 1995) . The circuits of discourse display and represent 'cases' throughout the modern teaching hospital. Formal grand rounds are paralleled by teaching rounds in which the explicit function of instructing medical students is foremost.
Clinical consultations provide the opportunity for the rehearsal of clinical authority. Consultant physicians do not merely display the classic signs and symptoms of diseases and syndromes; they also display their professional authority and status through a number of rhetorical devices. This rhetoric of clinical authority includes the narration of professional 'experience' and in this context the senior clinician has implicit -but powerful -rights to recount past cases and to ground medical knowledge within a biographical warrant. This biographical knowledge is grounded in the warrant of personal witnessing; an experienced clinician can lay claim to a store of firsthand observations. To have seen a case is to claim direct access to the signs and symptoms of cases and conditions. The phenomenology of the clinic is established by the overriding legitimacy of firsthand testimony.
The consultant discusses the diagnosis of Polymicrogyria with Annabel, an affected teenager and her mother [Polymicrogyria is caused by abnormalities of grey matter of the brain, can lead to developmental delay, speech difficulties, motor dysfunction of the mouth with drooling, seizures and increased muscle tone]. After describing the structural changes in her brain and discussing the MRI scans, the consultant adds that 'it's not uncommon.
It's rare, but I see it quite a lot. Annabel's pattern is typical'. [Clinic 11, patient 2]
In making a diagnosis, the consultant often commented on the rarity of the diagnosis and displayed her expertise by adding that she has seen many such cases 'I see quite a few and it's not unusual'. This young woman's subtle features and mild problems fit the diagnosis, but within the context of this specialism she is not unusual and such a seemingly 'rare' diagnosis is common for the consultant to make.
Equally, the claim that one has 'never' seen a syndrome, an associated feature, or a particular kind of clinical presentation, is powerful negative evidence against following a particular diagnosis or a line of argument.
For example, the case of a sixteen-year-old young woman who has been referred with suspected Noonan syndrome. Although the consultant agrees that a number of her problems 'heart problems, learning difficulties and short stature' do 'fit' within this classification, she is 'not aware that the facial features of Noonan's include prominent eyes and jaw'. She has not seen these features and so is unwilling to give a definitive classification until other investigations have been carried out, 'I've not come across the eyes before'.
Although there is no 'definite test' for this syndrome she decides to take blood and do a platelet count, because low platelets can also be a feature of Noonan syndrome, and the patient is due to have surgery in the near future. Because she has all the features that fit a 'classic' description of the syndrome, the diagnosis is fixed; she has 'the full house'. This is a classic example of traditional bedside diagnostics where the clinicians can read the pathogenomic signs in the patient's features, she is certain this patient will also have the chromosomal deletion associated with the syndrome (22q), she can 'see' it in her. This occasion is also a display of the consultant's specialist knowledge that other colleagues do not possess. The most significant features of Weaver's syndrome, accelerated growth and distinct facial features are more visible in babies and infants, but as they get older, the clinicians will have to rely on more subtle features, the 'look', in order to make a diagnosis. Faces can change over time and the skill of the clinician is to see a syndrome through and despite such changes, as the consultant instructs the juniors, 'faces change, they suddenly become something or they appear to grow out of something'. This is also associated with keeping people within the clinic; the patient may not have the 'look' of a specific syndrome but there is always the expectation that this may change. The subtlety of diagnosis means that the expertise of clinical geneticists is indispensable-only they can see the signs that indicate the child's problems have a genetic base.
At the dysmorphology meeting, they discuss the case of Joseph. The slide is shown and they exclaim variously that he is a 'gorgeous', 'very attractive' 'cute' little boy. As the consultant notes 'if he was running round Sainsbury's you wouldn't think anything'. However, she is not happy to discharge him from the clinic, she points out he has a syndactyly of the toes [the digits are joined], hands that are very soft and hyperextensible [joint laxity] and 'sausage-y fingers'. After they have looked at the slides for some time, the consultant adds, 'there's just something about him'. [Meeting 6, case 6] Thus, even though the child has a seemingly 'normal' appearance and passes 'the Sainsbury test', only their expertise can reveal the subtle signs of an underlying genetic problem. The team are unable to add anything else to aid diagnosis, but they agree to keep him within the clinic, as this may change.
'Seeing' also encompasses other senses, not just sight to make a diagnosis.
Touch, hearing and smell are also important for decoding the subtle signs of an underlying genetic problem. The physician, the clinical pathologist, the haematologist -these and others can all claim a special capacity to 'see'. The pathologist can see the forms of cells and lesions; the haematologist can read the evidence of a peripheral blood smear or a bone-marrow aspirate; the clinician can see and de-code the signs of diseases and syndromes. Oracular pronouncements invoke the almost sacred gaze of the clinic.
Genetic technologies
Although diagnosis and clinical classification are to some extent being reshaped by genetic technologies, in this section we show that clinical judgement is still central.
Molecular genetic tests do not necessarily enter the clinical process until after the team have reviewed other materials and sometimes they do not enter at all. So although for some cases a result using a molecular test may be viewed as the ultimate proof that a condition is genetic and that its origins reside within an individual's genes, for many of the conditions encountered in the dysmorphology clinic no test is available.
They discuss the case of Sam, a little boy with severe developmental delay. Although this child has a number of features that indicate that his problems have a genetic base, the clinician can 'see' that they do not have a genetic cause that can be identified using current technologies. The boy does not have 'the look' that indicates he has the type of mutation or deletion that can be identified by the molecular technologies currently available. However, they decide to keep him among the clinic's patients and to continue to monitor him; technologies may improve in the future. Thus, not being able to identify a molecular change (or indeed a specific syndrome) does not negate the possibility of identifying a genetic problem in general, even if a specific diagnosis is not available. Apart from the boy's short stature, there appear to be no other visual signs that the consultant can associate with a diagnosis of Russell-Silver. However, she does not dismiss the search for this diagnosis based on her clinical observations, there are a number of chromosomal rearrangements (for example, the maternal uniparental disomy 7 or UPD7 where both or part of both chromosome 7s are from the same parent) that have been associated with Russell-Silver syndrome. Research laboratories are increasingly discovering molecular changes in patient groups, however, the relationship between phenotype (the manifestations of the patient's condition) and the genotype (the underlying DNA or chromosomal anomaly) is not entirely predictable.
As in this case, a chromosomal change is associated with a syndrome, however, there are a group of patients with the same chromosomal change but who do not 'fit' the 'classic' clinical description of the syndrome. Thus, the process of the diagnosis and classification of syndromes is becoming increasingly harder to fix, there are always new molecular changes being identified and linked with syndromes by the research scientists that must be interpreted and adjudicated upon by the clinic.
There is a belief within the team that the technology will improve and the 'fit' between molecular findings (genotype) and clinical features (phenotype) will increase. Blood samples are routinely collected and stored in the expectation that these technologies will improve and provide families with more accurate or appropriate molecular tests in the near future.
At the end of the clinic, the consultant tells the parents of a little boy with The syndrome Polymicrogyria is being re-defined by molecular tests and renegotiated by the clinic. Although there is a 'common' type, the main features of which are 'epilepsy, drooling, gait abnormalities', there are also other sub-categories associated with changes on chromosome 21 and 22 that have been identified. Thus, for some syndromes, clinical diagnoses are developing a more subtle taxonomy in light of genetic laboratory work.
The remarkable rate of growth in new genetic techniques and the identification of a genetic basis for a wide range of conditions have had considerable implications for clinical medicine. It is now possible to use specific genetic tests to identify a number of conditions previously classified only in clinical terms. It would be wrong, however, to assume that there is a linear evolutionary sequence at work here -from clinical perception to laboratory testing. In the four decades since the first genetic investigations, genetic science has progressed rapidly, so that much smaller molecular and chromosomal changes can be determined. There are now potentially so many genetic alterations that can be detected that the element of clinical judgement is not so much being lost as re-directed into deciding which of the possible laboratory tests should be applied in the assessment of each case. Here the consultant considers a new genetic test to identify a molecular change, which is associated with learning difficulties and 'movements'. Only a skilled clinician can 'see' these subtle signs and associate them with the relevant genetic test.
The tests are dependent upon the skill of the clinician to align the 'sign' in the patient accurately with the appropriate molecular technology. The team often pronounced that they 'knew' a molecular change would or would not be present in an individual before they had received the test results, they could see its external expression in the individual's features. In the case above, they decide not to carry out a genetic test because they do not believe it would provide additional information and the clinical diagnosis and associated familial risk for the brother are fixed.
Expertise is similarly displayed in identifying the signs and symptoms that would find their expression in a specific molecular test. Thus, an important skill is knowing when a patient would be likely to get a positive test result. In this case, the team recognize the chromosomal change is likely to be there, they can 'see' it in his features. Although this boy does not have 'the face' that fits the classic features of the syndrome, the clinicians can identify the subtle sign (the curved fifth finger) that may be associated with a specific genetic test.
If the genetic technologies fail to reveal or identify the predicted chromosomal change, the team do not dismiss their diagnosis; rather the rhetoric of improving technology is employed or they transfer their search to other sites of the body such as skin, blood or brain.
In the team meeting they discuss the case of Jacob, a little boy who had 'got lots of problems, he's going to be adopted, lots of social issues'. The consultant says that she knows there is 'something in the chromosomes'.
However, 'we haven't found it yet, so we're looking at the skin', they were unable to locate the chromosomal change in his blood. [Meeting 1, case 5] The consultant can 'see' the chromosomal change in the child. Thus, the inspection of the body and recognition of their 'look' that fits a classification can lead to a negative genetic test result being dismissed. Rather than dismissing the clinical diagnosis, the team continues to look for the genetic change by moving to different sites of the body to confirm the clinical diagnosis, this time in the boy's skin. The embodiment of medical knowledge and authority here includes the competence to 'see' in a particularly adept and privileged way. The observation and recognition of classic signs and characteristic appearances are among the ways in which medical authority and disease entities are simultaneously constituted (Canguilhem 1989 ).
Discussion
We have described some deliberations of the clinic to illuminate how in practice genetic science informs clinical judgement, contributing to the configuration and reconfiguration of syndromes and cases. We have suggested that contemporary dysmorphology can be understood in terms of long-standing forms of medical knowledge, medical representations and medical discourse (King 1982) .
Notwithstanding the new forms of technology provided by genetic science (Casper and Koenig 1996; Keating and Cambrosio 2001) , 'the clinic' still asserts its symbolic and functional power: the 'gaze' of the clinician and the clinician's warrant of personal knowledge still exert their influence.
The work of the genetics services includes the ascription of specific named conditions to patients. This involves the assembly of a clinical description, including the characterization of the patient's physical appearance, including -but not exclusively -the appearance of the head and face. Clinicians decide whether appearances are 'normal' or 'abnormal', and -if abnormal -whether they correspond to a dysmorphic clinical entity. The classification itself has a degree of flexibility in it; we are here studying the process of making and re-making syndromes as well as their description. As Canguilhem (1992) classically pointed out, and as Keating and Cambrosio (2003) have more recently affirmed, the pathological is no mere extension of the biological, but is constituted by distinctive, shifting configurations of technique, judgment and representation. The clinic is a site in which entities are assembled, and is obdurately resistant to statistical or biological reduction. We are not witnessing a simple reductionist 'geneticisation' of medical knowledge in this context (cf. Hedgecoe 1998 Hedgecoe , 1999 Hedgecoe , 2003 Kerr 2000 Kerr , 2004 . There is no single hierarchy of knowledge-types. There are, however, hierarchical relations of expertise. Locally, assembling descriptions of typical abnormalities, and to adjudicate when perceived characteristics are adequately 'syndromic'. As a specialty, dysmorphology provides a rich and developing nosography. As we have indicated, the categorization of syndromes is not static. The classification and description of dysmorphic syndromes are subject to modification. This is, therefore, a nosography-in-the-making for some conditions at least. Dysmorphology has thus furnished us with a prime opportunity to document the processes of medical classification as it occurs (cf. Bowker and Star 1999) . We suggest that a broad historical and cultural pattern can be traced that brings together the spectacular display and the oracular pronouncement as long-standing (although by no means immutable) features of medical knowledge and the importance of a deeply entrenched visual and oral culture in the creation and transmission of medical knowledge.
